GlassScriptPhysician profile
Anureet Malhotra
NPI 1548835077
$3,297.94
in general payments reported to CMS, 2019-2025
7 companies · $2,923 in 2025
The $2,923 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $239 · 2024: $137 · 2025: $2,923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,744 · Travel and Lodging: $1,554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,744.35 |
| Travel and Lodging | $1,553.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,683.26 | 2025 | Gallant, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Paragonix Technologies, INC. | $238.58 | 2023 | Sherpacool Box, Paragonix Sherpapak Cardiac Transport System, Shipper Box |
| Boston Scientific Corporation | $176.70 | 2024-2025 | Ams 700 |
| Abiomed | $130.62 | 2025 | |
| Edwards Lifesciences Corporation | $29.68 | 2025 | |
| Medtronic, INC. | $23.19 | 2025 | Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $15.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anureet Malhotra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.